Lorrain Daniel S.
SEC insider (Form 3/4/5 filer). CIK 0001861550. Chief Scientific Officer at Contineum Therapeutics, Inc. (CTNM). 34 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in SAN DIEGO, CA.
Companies Lorrain Daniel S. has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Officer, Chief Scientific Officer
Lorrain Daniel S.
CIK: 0001861550
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Contineum Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Jul 9, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect25 shares at avg. $16.00$400 - Jul 9, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect25 shares at avg. $1.01$25.25 - Jul 8, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect1K shares at avg. $16.00$16K - Jul 8, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect1K shares at avg. $1.01$1K - Jul 1, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect2.5K shares at avg. $16.24$41K - Jul 1, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect5.9K shares at avg. $15.67$92K - Jul 1, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect4.2K shares at avg. $1.01$4K - Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect28.8K shares at avg. $16.04$462K - Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect28.8K shares at avg. $1.01$29K - Jun 1, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect4.2K shares at avg. $13.16$55K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 25 | $16.00 | $400 | Direct |
| Jul 9, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 25 | $1.01 | $25 | Direct |
| Jul 8, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 1,015 | $16.00 | $16,240 | Direct |
| Jul 8, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 1,015 | $1.01 | $1,025 | Direct |
| Jul 1, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 2,501 | $16.24 | $40,608 | Direct |
| Jul 1, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 5,852 | $15.67 | $91,682 | Direct |
| Jul 1, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 4,183 | $1.01 | $4,225 | Direct |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 28,826 | $16.04 | $462,288 | Direct |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 28,826 | $1.01 | $29,114 | Direct |
| Jun 1, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 4,170 | $13.16 | $54,862 | Direct |
1-10 of 34 transactions